Welcome to our dedicated page for The Joint news (Ticker: $JYNT), a resource for investors and traders seeking the latest updates and insights on The Joint stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect The Joint's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of The Joint's position in the market.
Rhea-AI Summary
The Joint Corp. (NASDAQ: JYNT) partners with the St. Louis Blues of the NHL, expanding its professional sports sponsorship. The partnership aims to provide routine and affordable chiropractic care to athletes, supporters, and the general public. Chiropractic care has gained widespread use among professional and amateur sports teams, offering rehabilitation and injury prevention. The Joint Chiropractic has 19 clinics in the greater St. Louis area, aiming to provide high-quality, accessible care to Blues fans and the community.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.83%
Tags
-
Rhea-AI Summary
The Joint Corp. (NASDAQ: JYNT) Announces 'Back Friday' Offering for Chiropractic Care Packages, Providing Additional Visits to Support Overall Health During the Holiday Season
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
-
Rhea-AI Summary
The Joint Corp (NASDAQ: JYNT) reported Q3 2023 financial results, with an 11% revenue growth to $29.5 million and an operating loss of $898,000. The company plans to convert most corporate clinics to franchised ones, aiming to drive growth. The financial report also includes a comparison of Q3 2023 and Q3 2022, as well as a reaffirmation of 2023 financial and clinic opening guidance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.89%
Tags
Rhea-AI Summary
The Joint Corp. (NASDAQ: JYNT) appoints Jeff Gramm to the board of directors and nominates him for election at the 2024 Annual Meeting of shareholders. Gramm's fund is a long-time investor in The Joint, owning 26.69% of the shares outstanding. The appointment is part of a Nominating and Standstill Agreement with Bandera Partners, LLC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.37%
Tags
-
Rhea-AI Summary
The Joint Corp. will report its Q3 2023 financial results on November 9, 2023. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.59%
Tags
-
Rhea-AI Summary
The Joint Corp. ranked on Franchise Times Top 400 list
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.42%
Tags
Rhea-AI Summary
The Joint Corp. opens its first location in West Virginia, expanding its footprint to 42 states. The new clinic in Morgantown is strategically located near WVU and busy communities, offering convenient and affordable chiropractic care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.54%
Tags
-
Rhea-AI Summary
The Joint Corp. announces sponsorship agreement with Fresno State Athletics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.68%
Tags
-
Rhea-AI Summary
The Joint Corp. reports preliminary Q2 2023 revenue growth of 18% and adjusted EBITDA growth of 23% compared to Q2 2022. Evaluating programs to cull approximately 10% of the corporate portfolio.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.64%
Tags
Rhea-AI Summary
The Joint Corp. (NASDAQ: JYNT) plans to restate previously issued financial statements due to incorrect treatment of re-acquired Regional Developer Rights and transfer pricing adjustments. The restatement is expected to result in a reduction of net income by $1.2M for the year ended December 31, 2022. However, the impact on Adjusted EBITDA, cash, cash equivalents, and restricted cash is estimated to be minimal. The company will hold a conference call to discuss the results for the second quarter of 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.87%
Tags
The Joint Corp.
Nasdaq:JYNT
JYNT Rankings
JYNT Stock Data
240.76M
10.58M
1.53%
78.27%
5.29%
Lessors of Nonfinancial Intangible Assets (except Copyrighted Works)
Real Estate and Rental and Leasing
United States of America
SCOTTSDALE
About JYNT
the joint was founded in tucson in 1999 by dr. fred gerretzen, whose vision was to turn the traditional and often misunderstood concept of routine chiropractic care into a simple and affordable reality. today, the joint delivers on that vision, with convenient locations nationwide whose shared purpose is to improve our patients' quality of life through routine and affordable chiropractic care. our mission. our mission is to improve quality of life through routine and affordable chiropractic care. that's why we built a nationwide network of modern, comfortable chiropractic locations staffed with experienced, licensed chiropractors. our membership plans are designed to make chiropractic care accessible, and our no-insurance-necessary approach to chiropractic care is revolutionizing the way people receive health care— putting the relationship back where it belongs, between you and your doctor. at the joint, we strive to maintain the highest quality of care and professionalism, while